학술논문
Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1–2 trial
Document Type
Article
Author
Deville, Jaime G; Carter, Michele F; Mansky, Hannah; Pinto, Jorge A; Ferreira, Flavia F; Romeiro, Juliana; D'Angelo, Jessica; Williams, Ruth; Jundi, Fernanda; Cruz, Maria Letícia Santos; Sidi, Claude Leon; Kataike, Hajira; Owor, Maxensia; Ahimbisibwe, Grace Miriam; van Rensburg, Ms Anita Janse; Andrea, Catherine V; Ponatshego, Ponego L; Budu, Marian; Tirelo, Lesedi; Masheto, Gaerolwe R; Raesi, Mpho S.; Ramogodiri, Moakanyi; Chanthong, Jiraporn; Khamrong, Chintana; Aurpibul, Linda; Fairlie, Lee; Patel, Faeezah; Soma-Kashiram, Hamisha; Archary, Moherndran; Hanley, Sherika; Govender, Vani; Sturzbecher, Fernanda Tomé; Cervi, Maria Célia; Mmbaga, Blandina T; Njau, Boniface; Matibe, Petronilla; Mukonowenzou, Ruvimbo; Marozva, Catherine C; Keter, Winnie C; Bii, Priscilla C; Ounchanum, Pradthana; Cressey, Tim R; Sukrakanchana, Pra-ornsuda; Chokephaibulkit, Kulkanya; Rungmaitree, Supattra; Pilotto, Jose Henrique; Fernandes, Luis Eduardo; Gomes, Ivete Martins; Ruel, Theodore D ; Acosta, Edward P; Liu, Jessica P; Gray, Kathryn P; George, Kathleen; Montañez, Nicole; Popson, Stephanie; Buchanan, Ann M; Bartlett, Mattie; Dayton, Dale; Anthony, Patricia; Brothers, Cynthia; Vavro, Cynthia; Singh, Rajendra; Koech, Lucy; Vhembo, Tichaona; Dobbels, Els F M; Hazra, Rohan; Townley, Ellen; Wiznia, Andrew
Source
In The Lancet HIV May 2022 9(5):e332-e340
Subject
Language
ISSN
2352-3018